7 january 2022, Mumbai
Scigenomics zooms as Novel healthcare startup
Scigenomics, a Mumbai based Nextgen healthcare company enters into agreement with Leucine Rich Bio, for the microbiome investigation services . As per the current global researches, the root cause of many diseases is just the imbalance of microorganisms present in the gut. Since this investigation of stool (faeces) involves DNA analysis, it is a high precision and technology-based investigation available, only at select centres of the world.
Dr B.S.Rajput, a renowned stem cell transplant surgeon & founding chairman of Scigenomics explains that this microbiome investigation will help a lot in the management of various Auto-immune disorders & intractable diseases like Diabetes , Rheumatoid Arthritis , obesity & Autism. It is also going to assist a lot of gastroenterologists in the management of Crohn’s disease, Irritable bowel syndrome and colon cancer.
As per management of Scigenomics , they are already doing various genetic investigations in collaboration with Mapmygenome a leading genetic investigation company. They are getting a lot of samples for Prenatal tests to detect probability of chromosomal disorders and genetic diseases in new borns like Down syndrome and muscular dystrophies . The company is also noting upcoming trend in the genetic investigations , needed in the management of various cancer patients like BRCA 1 & 2, done in breast cancer patients.
Incidentally severe cytokine storm, the main cause of death in some of COVID-19 patients has been attributed to dysbiosis, which could have been diagnosed by microbiome test & corrected by simple dietary changes/ supplements.
Dr Rajput is an expert stem cell transplant surgeon with 35 years of experience and believes that new treatment modalities require advanced and next generation investigation services. He says “a combination of high-tech investigations like microbiome test and personalized cellular therapies can give miraculous results in no option diseases like Amyotrophic lateral sclerosis, Rheumatoid Arthritis and inter stitial lung disease. He also emphasized that the microbiome investigation can help a lot of COVID patients, where post COVID syndrome is posing a big problem.
Anti-aging is currently the subject of attention globally where wellness is the mantra & disease free aging. In this pursuit the company is providing antiaging and regenerative medicines services in collaboration with KLS Wellness institute.
Scigenomics is a fast growing start up which is changing the concepts of patient management using a novel platform where lot of next generation healthcare services are being provided at your door step and that too at most competitive prices.
www.scigenomics.com +919820800187, 9820850187
13 April 2021, Mumbai
Scigenomics, a Nextgen Healthcare company enters into Microbiome space
Scigenomics, a Mumbai based Nextgen healthcare company enters into agreement with Leucine Rich Bio, for the microbiome investigation services for its patients and clients. As per the current global researches, the root cause of many diseases is just imbalance of micro organisms present in the gut. Since this investigation of stool (faeces) involves DNA analysis , it is high precision and technology based investigation available ,only at select centres of the world.
Dr B.S.Rajput, a renowned stem cell transplant surgeon & founding chairman of Scigenomics explains that this microbiome investigation will help a lot in the management of various Auto-immune disorders & intractable diseases like Diabetes , Rheumatoid Arthritis , obesity & Autism. It is also going to assist a lot of gastroenterologists in the management of Crohn’s diseases, Irritable bowel syndrome and colon cancer.
As per management of Scigenomics , they are soon going to launch various genetic investigations & personalized cellular therapies, for arthritis knee, spinal cord injury and neurodegenerative disorders specially ALS & multiple sclerosis.
This microbiome investigation would give a comprehensive report about Dysbiosis or imbalance in the ratio of various bacteria, virus and other organisms, in the gut. A team of medical and nutritional consultants would also suggest for corrective measures. Incidentally severe cytokine storm found in some of COVID-19 patients has been attributed to dysbiosis, where depletion of gut bacteria with known anti-inflammatory effect was noted.
Dr Rajput is an expert stem cell transplant surgeon with 35 years of experience and he believes that new treatment modalities require advanced and next generation tools and services. He says “a combination of high tech investigations like microbiome investigations and personalized cellular therapies can give miraculous results in no option diseases like Amyotrophic lateral sclerosis, Rheumatoid Arthritis and interstitial lung disease. He further says that with the establishment of Gut-Lung axis, the microbiome investigation can help a lot of COVID patients, where post COVID syndrome is posing a big problem.
Dr Rajput also emphasize that Anti-aging is currently the subject of attention globally where aim is prevention of diseases & disease free longer life. In such cases microbiome investigation would be part of all assessment protocols and cell therapy of treatment protocols.”
www.scigenomics.in +919820800187, 9820850187
